Citrobacter freundii, a common cause of nosocomial infections leading to diarrhea, urinary tract infection
and meningitis, is increasingly becoming multidrug resistant. The current study was aimed to determine
the prevalence and antibiotic susceptibility pattern of extended spectrum ß-lactamases producing C.
freundii clinical isolates. A total of 2950 clinical samples were collected from both hospitalized and nonhospitalized
patients of Khyber Teaching Hospital (KTH), Peshawar, and processed by for isolation of C.
freundii followed by phenotypic detection of ß-lactamases and antimicrobial susceptibility profile. Our
results indicated that a total of 130(4.40%;130/2950) samples were positive for C. freundii comprised
of urine 58.46%, pus 33.85% and wounds 7.69%, respectively. More samples from females (n=70) than
males (n=60) with majority (43.08%) from age group 21-40 years were found positive for C. freundii.
Of the 130 isolates, 28 (21.53%) were ESBL producers comprised of 10 (35.71%) from males and
18(64.29%) from females with majority recovered from age group of 21–40 years (57.14%). Furthermore,
10(7.69%) isolates were metallo-ß lactamase (MBL) producers containing 4(40%) from males and 6(60%)
from females with majority from age group of 41–60 years (60%). Of the ESBL producers, 78.57%,
71.42%, 64.29%, and 42.86% isolates displayed resistance against trimethoprim-sulphamethoxazole,
levofloxacin, ciprofloxacin and piperacillin-tazobactam, respectively, while, tygacil and colistin showed
100% susceptibility. On the other hands, 60%, 80%, 40% and 20% of metallo-ß lactamase producers
were found resistant to trimethoprim-sulphamethoxazole, levofloxacin, ciprofloxacin and piperacillintazobactam,
respectively. Overall, current results show a high number of isolates resistant to commonly
used drugs, and hence appropriate usage of antibiotics must be ensured to avoid further dissemination.